Can you provide the last earnings date for CRESCENT BIOPHARMA INC?
CRESCENT BIOPHARMA INC (CBIO) last reported earnings on 2/26/2026.
CRESCENT BIOPHARMA INC (CBIO) Earnings History & Surprises
NASDAQ:CBIO • KYG2545C1042
Current stock price
21.28 USD
+1.83 (+9.41%)
At close:
21.28 USD
0 (0%)
After Hours:
CBIO Earnings overview
Past quarterly earnings results for CRESCENT BIOPHARMA INC (CBIO), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- N/A
- Period
- Q1 / 2026
- EPS Estimate
- -$0.97
- Revenue Estimate
- 364.283K
Last Reported
Most Recent- Release Date
- Feb 26, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.54
- EPS Surprise
- 78.96%
- Revenue Surprise
- 218.94%
Beat Rate
Last 8 Quarters 0%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.54 | -2.57 | 78.96% | -230.88% | 10.844M | 3.4M | 218.94% | - |
| Q3 2025 | -1.27 | -2.02 | 37.18% | -1,031.91% | - | - | ||
| Q2 2025 | -4.93 | -1.80 | -174.23% | 69.19% | - | - | ||
| Q1 2025 | -4.00 | -5.10 | 21.57% | 76.47% | - | - | ||
| Q4 2024 | -0.16 | - | 98.83% | - | -100.00% | |||
| Q3 2024 | -0.11 | - | 99.20% | - | - | |||
| Q2 2024 | -16.00 | -17.09 | 6.35% | -23.08% | - | - | ||
| Q1 2024 | -17.00 | -16.83 | -1.01% | - | - | - | ||
| Q4 2023 | -14.00 | -15.56 | 10.00% | 26.32% | 10K | - | - | |
| Q3 2023 | -14.00 | -14.62 | 4.24% | 12.50% | - | - | ||
| Q2 2023 | -13.00 | -18.70 | 30.48% | 48.00% | - | -100.00% | ||
| Q1 2023 | -17.00 | -17.00 | 0.00% | 39.29% | - | - | ||
| Q4 2022 | -19.00 | -17.00 | -11.76% | 42.42% | - | -100.00% | ||
| Q3 2022 | -16.00 | -26.86 | 40.43% | 52.94% | - | -100.00% | ||
| Q2 2022 | -25.00 | -29.07 | 14.00% | 10.71% | 80K | - | - | |
| Q1 2022 | -28.00 | -31.28 | 10.49% | - | - | -100.00% | ||
| Q4 2021 | -33.00 | -34.43 | 4.14% | -3.13% | 20K | - | -87.50% | |
| Q3 2021 | -34.00 | -32.39 | -4.99% | -17.24% | 90K | - | -91.00% | |
| Q2 2021 | -28.00 | -31.37 | 10.73% | 12.50% | - | - | ||
| Q1 2021 | -28.00 | -32.44 | 13.68% | -55.56% | 1.06M | - | -88.22% | |
| Q4 2020 | -32.00 | -32.84 | 2.57% | - | 160K | 204K | -21.57% | - |
| Q3 2020 | -29.00 | -33.46 | 13.32% | - | 1M | - | - | |
| Q2 2020 | -32.00 | -38.76 | 17.44% | - | - | - | ||
| Q1 2020 | -18.00 | -31.01 | 41.95% | - | 9M | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
-9.13%
Max EPS beat (4)
78.96%
Min EPS beat (4)
-174.23%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, CBIO has beaten EPS estimates in 3 out of 4 releases
In the last 4 quarters, CBIO reported -9.1% below the EPS estimates on average.
Related analysis
CRESCENT BIOPHARMA INC / CBIO Earnings FAQ
Did CBIO stock beat earnings estimates in the most recent quarter?
CRESCENT BIOPHARMA INC (CBIO) beat EPS estimates and beat revenue estimates in the most recent quarter.
What percentage of the time does CBIO stock beat earnings estimates?
In the last 4 quarters, CRESCENT BIOPHARMA INC (CBIO) has beaten EPS estimates in 3 out of 4 releases.